SEC Form 4 · accession 0001250853-17-000022
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Chin
Officer — President & CEO · Director · 10% Owner
Period of report
May 17, 2016
Accepted (ET)
Jan 25, 2017 · 8:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 17, 2016 | G | 400,000 | $0.00 | D | 2,223,546 | D | |
| Common Stock | Jan 23, 2017 | A | 100,000 | $0.00 | A | 2,323,546 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $6.40 | Jan 23, 2017 | A | 175,000 | A | — | Jan 23, 2027 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F1This transaction involved a gift of securities by the reporting person to a family trust.
- F2The option will vest as to 25% after one year following the date of grant, and the remainder will vest in equal monthly installments over the following three years.